| Line Item | 2025-04-30 | Y/Y |
|---|---|---|
| R&D Expense | $16K | — |
| SG&A Expense | $1.8M | +1842.2% |
| Operating Income | -$2.5M | -325.7% |
| Interest Expense | $71K | -44.9% |
| Net Income | -$3.4M | -374.3% |
| Line Item | 2025-04-30 | Y/Y |
|---|---|---|
| Current Assets | $16K | -69.9% |
| Total Assets | $16K | -99.1% |
| Current Liabilities | $1.2M | +11.3% |
| Total Liabilities | $1.2M | +11.3% |
| Stockholders' Equity | -$1.1M | -260.4% |
| Line Item | 2025-04-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$797K | -134.0% |
| Financing Cash Flow | $809K | +503.7% |